LG37597-8Buprenorphine|
Basic Attributes
- Version First Released
- Pending promotion to Production status
- Parent Group
-
LG80-4 Drug/ToxPotentialForAbuse<SAME:Comp><ROLLUP:Prop|
Tm| Sys| Meth> - Group Category
- Drugs of abuse
LOINC FHIR® API Example - ValueSet Request Get Info
https://fhir.loinc.org/ValueSet/?url=http://loinc.org/vs/LG37597-8
LOINC Terms in this Group
| 16208-1 | Buprenorphine [Presence] in Urine by Confirmatory method |
| 16495-4 | Buprenorphine [Units/volume] in Serum or Plasma |
| 16496-2 | Buprenorphine [Units/volume] in Urine |
| 3413-2 | Buprenorphine [Mass/volume] in Serum or Plasma |
| 3414-0 | Buprenorphine [Presence] in Urine |
| 3415-7 | Buprenorphine [Mass/volume] in Urine |
| 3416-5 | Buprenorphine [Mass/time] in 24 hour Urine |
| 49752-9 | Buprenorphine [Mass/volume] in Urine by Confirmatory method |
| 53846-2 | Buprenorphine [Mass/volume] in Serum or Plasma by Confirmatory method |
| 72762-8 | Buprenorphine [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
| 73942-5 | Buprenorphine [Presence] in Saliva (oral fluid) by Screen method |
| 75367-3 | Buprenorphine [Mass/mass] in Meconium by Confirmatory method |
| 75368-1 | Buprenorphine [Mass/volume] in Serum, Plasma or Blood |
| 77204-6 | Buprenorphine [Presence] in Saliva (oral fluid) by Confirmatory method |
| 77205-3 | Buprenorphine [Presence] in Meconium by Screen method |
| 79138-4 | Buprenorphine [Presence] in Blood by Confirmatory method |
| 79139-2 | Buprenorphine [Presence] in Blood by Screen method |
| 82369-0 | Buprenorphine [Presence] in Serum or Plasma by Screen method |
| 82372-4 | Buprenorphine [Presence] in Gastric fluid by Screen method |
| 82373-2 | Buprenorphine [Presence] in Specimen by Screen method |
| 93494-3 | Buprenorphine [Presence] in Urine by Screen method |
LOINC Copyright
Copyright © 2022 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright